Teerapon Dhippayom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Teerapon Dhippayom has a total of 249 co-authors. Here are the top co-authors by number of shared publications:
- Nathorn Chaiyakunapruk
Department of Pharmacotherapy, College of Pharmacy University of Utah Salt Lake City Utah USA
24 shared publications Nathorn Chaiyakunapruk
The University of Utah College of Pharmacy
12 shared publicationsPiyameth Dilokthornsakul
Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Thailand (Dr. Theerasuwipakorn and Dilokthornsakul); Center for Medical and Health Technology Assessment (CM-HTA), Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand (Dr. Nimworapan and Dilokthornsakul)
12 shared publicationsKansak Boonpattharatthiti
11 shared publications- Ines Krass
Faculty of Medicine and Health, The University of Sydney School of Pharmacy, The University of Sydney, Sydney, Australia
8 shared publications - Chuenjid Kongkaew
Centre for Safety and Quality in Health, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
7 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (11) , e72557
Impact of Mulberry Consumption on Glycemic Indices and Lipid Profiles: An Umbrella Review
The growing worldwide prevalence of type 2 Diabetes Mellitus (T2D) and dyslipidemia requires the identification of effective plant‐based management approaches, including the use of mulberry. However, the clinical evidence about the effects of mulberry on glucose and lipid profiles is inconsistent. This umbrella review studied evidence from five meta‐analyses (MAs) to comprehensively evaluate the impact of mulberry on glycemic and lipid profiles. Systematic searches were performed across major databases with methodological quality and certainty of evidence examined using AMSTAR‐2 and GRADE criteria, respectively. Low‐certainty evidence suggested that mulberry twig alkaloids reduced glycated hemoglobin (HbA1c) in adults with T2D compared with placebo (MD: −0.51%, 95% CI: −0.92 to −0.09). Moderate‐certainty evidence demonstrated that mulberry consumption significantly reduced fasting blood glucose (MD: −34.23 mg/dL, 95% CI: −55.13 to −13.33) and triglycerides (MD: −45.17 mg/dL, 95% CI: −70.86 to −19.49) in adults with T2D. In adults with medical conditions, mulberry also reduced total cholesterol (MD: −13.13 mg/dL; 95% CI: −19.06 to −7.20) and LDL‐C (MD: −8.84 mg/dL; 95% CI: −13.26 to −4.42), with low‐certainty evidence. By contrast, mulberry intake was not associated with changes in fasting plasma insulin and HDL‐C. All five MAs were rated as having critically low methodological quality according to AMSTAR‐2. Therefore, while mulberry may offer potential as a supportive supplement for cardiometabolic management, these findings should be interpreted with caution, are considered preliminary given the critically low methodological quality and the low‐to‐very‐low certainty of evidence for several statistically significant findings, and high‐quality clinical research is needed to strengthen the evidence base.
- 13 November 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (11) , e72557
Open AccessImpact of Mulberry Consumption on Glycemic Indices and Lipid Profiles: An Umbrella Review
The growing worldwide prevalence of type 2 Diabetes Mellitus (T2D) and dyslipidemia requires the identification of effective plant‐based management approaches, including the use of mulberry. However, the clinical evidence about the effects of mulberry on glucose and lipid profiles is inconsistent. This umbrella review studied evidence from five meta‐analyses (MAs) to comprehensively evaluate the impact of mulberry on glycemic and lipid profiles. Systematic searches were performed across major databases with methodological quality and certainty of evidence examined using AMSTAR‐2 and GRADE criteria, respectively. Low‐certainty evidence suggested that mulberry twig alkaloids reduced glycated hemoglobin (HbA1c) in adults with T2D compared with placebo (MD: −0.51%, 95% CI: −0.92 to −0.09). Moderate‐certainty evidence demonstrated that mulberry consumption significantly reduced fasting blood glucose (MD: −34.23 mg/dL, 95% CI: −55.13 to −13.33) and triglycerides (MD: −45.17 mg/dL, 95% CI: −70.86 to −19.49) in adults with T2D. In adults with medical conditions, mulberry also reduced total cholesterol (MD: −13.13 mg/dL; 95% CI: −19.06 to −7.20) and LDL‐C (MD: −8.84 mg/dL; 95% CI: −13.26 to −4.42), with low‐certainty evidence. By contrast, mulberry intake was not associated with changes in fasting plasma insulin and HDL‐C. All five MAs were rated as having critically low methodological quality according to AMSTAR‐2. Therefore, while mulberry may offer potential as a supportive supplement for cardiometabolic management, these findings should be interpreted with caution, are considered preliminary given the critically low methodological quality and the low‐to‐very‐low certainty of evidence for several statistically significant findings, and high‐quality clinical research is needed to strengthen the evidence base.
- Open Access
- 19 September 2026
- Published by Elsevier in Phytomedicine Plus
- Vol. 6 (4)
Exploring clinical effects of Yahom Theppachit: a systematic review and meta-analysis
- 19 September 2026
- Published by Elsevier in Phytomedicine Plus
- Vol. 6 (4)
Open AccessExploring clinical effects of Yahom Theppachit: a systematic review and meta-analysis
- Open Access
- 10 September 2026
- Published by Elsevier in Phytomedicine Plus
- Vol. 6 (4)
Clinical evidence for Acanthus spp. in dermatological conditions: A systematic review
- 10 September 2026
- Published by Elsevier in Phytomedicine Plus
- Vol. 6 (4)
Open AccessClinical evidence for Acanthus spp. in dermatological conditions: A systematic review
- Open Access
- 3 September 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (9) , e70316
Estimating the National Disease Burden and Economic Burden of Respiratory Syncytial Virus (RSV) in Thailand
Background: Respiratory syncytial virus (RSV), a single‐stranded negative‐sense RNA virus, causes respiratory tract infections in children and adults, leading to hospitalization and mortality. However, the national disease burden and economic impact of RSV in Thailand remain undetermined. This study aims to estimate the national disease and economic burden of RSV infections in 2023 in Thailand. Methods: An incidence‐based approach was employed to estimate the economic burden of RSV from a societal perspective. RSV incidences were calculated from the data obtained from six sentinel surveillance sites across Thailand. The distribution of adjusted age‐specific incidence was employed to estimate RSV cases across different age groups. A micro‐costing technique with a bottom‐up method was used to calculate direct medical costs, direct non‐medical costs, and indirect costs. The results were reported in Thai Baht (THB) and USD (34.96THB = 1 USD). Results: An estimated 122,631 RSV cases occurred in 2023 (186 per 100,000 person‐years), with 20,842 hospitalizations (17.0%) and 1156 premature deaths (5.5%). The total economic burden was 6.2 billion THB (177 million USD), or 0.03% of Thailand's gross domestic product (GDP). This included 1 billion THB (29 million USD) in direct medical costs, 349 million THB (9.9 million USD) in direct non‐medical costs, and 4.8 billion THB (138 million USD) in indirect costs. Productivity loss from RSV‐related premature deaths was the main cost driver, accounting for 69.35% of the total burden. Conclusion: RSV infection poses a substantial economic burden in Thailand, emphasizing the urgent need for targeted interventions and public health policies to reduce its impact.
- 3 September 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (9) , e70316
Open AccessEstimating the National Disease Burden and Economic Burden of Respiratory Syncytial Virus (RSV) in Thailand
Background: Respiratory syncytial virus (RSV), a single‐stranded negative‐sense RNA virus, causes respiratory tract infections in children and adults, leading to hospitalization and mortality. However, the national disease burden and economic impact of RSV in Thailand remain undetermined. This study aims to estimate the national disease and economic burden of RSV infections in 2023 in Thailand. Methods: An incidence‐based approach was employed to estimate the economic burden of RSV from a societal perspective. RSV incidences were calculated from the data obtained from six sentinel surveillance sites across Thailand. The distribution of adjusted age‐specific incidence was employed to estimate RSV cases across different age groups. A micro‐costing technique with a bottom‐up method was used to calculate direct medical costs, direct non‐medical costs, and indirect costs. The results were reported in Thai Baht (THB) and USD (34.96THB = 1 USD). Results: An estimated 122,631 RSV cases occurred in 2023 (186 per 100,000 person‐years), with 20,842 hospitalizations (17.0%) and 1156 premature deaths (5.5%). The total economic burden was 6.2 billion THB (177 million USD), or 0.03% of Thailand's gross domestic product (GDP). This included 1 billion THB (29 million USD) in direct medical costs, 349 million THB (9.9 million USD) in direct non‐medical costs, and 4.8 billion THB (138 million USD) in indirect costs. Productivity loss from RSV‐related premature deaths was the main cost driver, accounting for 69.35% of the total burden. Conclusion: RSV infection poses a substantial economic burden in Thailand, emphasizing the urgent need for targeted interventions and public health policies to reduce its impact.
- Open Access
- 22 July 2026
- Published by Wiley in Obesity Reviews
Cardiovascular Outcomes of GLP‐1–Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta‐Analyses of Randomized Controlled Trials
Introduction: Cardiovascular (CV) outcomes of Glucagon‐like peptide‐1 (GLP‐1)–based medicines among people with overweight and obese (OW/OB) population have been investigated by meta‐analyses of randomized controlled trials (RCTs), but an overall summary is lacking. Methods: PubMed, EMBASE, Epistemonikos, and Cochrane databases were searched till May 2024 for meta‐analyses of RCTs that assessed CV outcomes of GLP‐1–based medicines among people with OW/OB. GRADE approach was used to assess strength of associations. Results: Nine studies with 58 unique meta‐analyses were included. Fifteen (25.9%) associations were statistically significant. Five high certainty evidence demonstrated beneficial effects of GLP‐1 RAs on any CV events ( N = 1), major adverse cardiac events (MACE) ( N = 2), and myocardial infarction (MI) ( N = 2), whereas two associations on revascularization ( N = 1) and CV events ( N = 1) were supported by moderate certainty. Four associations demonstrated inverse effects of tirzepatide on MACE ( N = 1; moderate) and hypertension ( N = 3; low). Remaining four demonstrated higher risk of arrhythmia with GLP‐1 RAs ( N = 1; moderate) and increased heart rate with tirzepatide ( N = 3; low to moderate). Although the inverse association between GLP‐1 RAs and MACE and MI was significant and supported by high certainty evidence in both main and sensitivity analyses, these associations were no longer statistically significant among patients without CV disease (CVD) at baseline. Conclusion: Findings suggest that GLP‐1 RAs are associated with reduced risk of MACE, and MI among people with OW/OB, but they were driven by studies with established CVD at baseline.
- 22 July 2026
- Published by Wiley in Obesity Reviews
Open AccessCardiovascular Outcomes of GLP‐1–Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta‐Analyses of Randomized Controlled Trials
Introduction: Cardiovascular (CV) outcomes of Glucagon‐like peptide‐1 (GLP‐1)–based medicines among people with overweight and obese (OW/OB) population have been investigated by meta‐analyses of randomized controlled trials (RCTs), but an overall summary is lacking. Methods: PubMed, EMBASE, Epistemonikos, and Cochrane databases were searched till May 2024 for meta‐analyses of RCTs that assessed CV outcomes of GLP‐1–based medicines among people with OW/OB. GRADE approach was used to assess strength of associations. Results: Nine studies with 58 unique meta‐analyses were included. Fifteen (25.9%) associations were statistically significant. Five high certainty evidence demonstrated beneficial effects of GLP‐1 RAs on any CV events ( N = 1), major adverse cardiac events (MACE) ( N = 2), and myocardial infarction (MI) ( N = 2), whereas two associations on revascularization ( N = 1) and CV events ( N = 1) were supported by moderate certainty. Four associations demonstrated inverse effects of tirzepatide on MACE ( N = 1; moderate) and hypertension ( N = 3; low). Remaining four demonstrated higher risk of arrhythmia with GLP‐1 RAs ( N = 1; moderate) and increased heart rate with tirzepatide ( N = 3; low to moderate). Although the inverse association between GLP‐1 RAs and MACE and MI was significant and supported by high certainty evidence in both main and sensitivity analyses, these associations were no longer statistically significant among patients without CV disease (CVD) at baseline. Conclusion: Findings suggest that GLP‐1 RAs are associated with reduced risk of MACE, and MI among people with OW/OB, but they were driven by studies with established CVD at baseline.
- Open Access
- 29 June 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Effectiveness of virtual reality disaster education on the performance of nursing students: a systematic review and meta-analysis
Disaster education is essential in nursing students to prepare students for crises. Virtual reality (VR) technology offers a promising training approach. To estimate the difference in performance, time to complete performance, cognitive learning, and self-efficacy of nursing students in VR disaster education compared to traditional education only. PubMed, EMBASE, CENTRAL, CINAHL, and ProQuest Dissertations & Theses Global were searched from inception to 22 January 2025. We included randomized controlled trials (RCTs) and non-RCTs that investigated the effect of VR disaster education on performance, time to complete performance, cognitive learning, and self-efficacy. The Risk Of Bias In Non-randomized Studies of Interventions, Version 2 (ROBINS-I V2) was used to assess risk of bias. A random-effects model was used to pool the effect estimates across studies. I2 was used to quantify statistical heterogeneity among included non-RCTs. The protocol of this study was registered in PROSPERO (CRD420250652860). Of the 307 articles identified, two quasi-experimental studies (non-RCTs) were included (n = 220). The time to complete the performance was significantly lower in the VR disaster education compared to the control group (mean difference [MD]: -45.18 s; 95% confidence interval [CI]; -52.06 to -38.30), with no evidence of heterogeneity (I2 = 0%). No significant difference was observed between VR and the control group for performance score (MD: -0.14; 95%CI; -1.98 to 1.70; I2 = 96%) and cognitive learning (MD: 3.56; 95%CI; -3.12 to 10.25; I2 = 99%), both showing considerable heterogeneity. No safety concern was reported in any of the included studies. VR-based disaster education has the potential to improve completion times in decontamination scenarios, which may contribute to enhanced nursing students' efficiency in emergency response. However, its effects on performance scores and cognitive learning remain inconclusive, due to non-significant pooled estimates and considerable heterogeneity across studies. Further high-quality RCTs with longer intervention durations are needed to validate these findings.
- 29 June 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessEffectiveness of virtual reality disaster education on the performance of nursing students: a systematic review and meta-analysis
Disaster education is essential in nursing students to prepare students for crises. Virtual reality (VR) technology offers a promising training approach. To estimate the difference in performance, time to complete performance, cognitive learning, and self-efficacy of nursing students in VR disaster education compared to traditional education only. PubMed, EMBASE, CENTRAL, CINAHL, and ProQuest Dissertations & Theses Global were searched from inception to 22 January 2025. We included randomized controlled trials (RCTs) and non-RCTs that investigated the effect of VR disaster education on performance, time to complete performance, cognitive learning, and self-efficacy. The Risk Of Bias In Non-randomized Studies of Interventions, Version 2 (ROBINS-I V2) was used to assess risk of bias. A random-effects model was used to pool the effect estimates across studies. I2 was used to quantify statistical heterogeneity among included non-RCTs. The protocol of this study was registered in PROSPERO (CRD420250652860). Of the 307 articles identified, two quasi-experimental studies (non-RCTs) were included (n = 220). The time to complete the performance was significantly lower in the VR disaster education compared to the control group (mean difference [MD]: -45.18 s; 95% confidence interval [CI]; -52.06 to -38.30), with no evidence of heterogeneity (I2 = 0%). No significant difference was observed between VR and the control group for performance score (MD: -0.14; 95%CI; -1.98 to 1.70; I2 = 96%) and cognitive learning (MD: 3.56; 95%CI; -3.12 to 10.25; I2 = 99%), both showing considerable heterogeneity. No safety concern was reported in any of the included studies. VR-based disaster education has the potential to improve completion times in decontamination scenarios, which may contribute to enhanced nursing students' efficiency in emergency response. However, its effects on performance scores and cognitive learning remain inconclusive, due to non-significant pooled estimates and considerable heterogeneity across studies. Further high-quality RCTs with longer intervention durations are needed to validate these findings.
- 24 April 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 180, 108723
Clinical effects of pharmacological and electronic cigarette interventions for smoking cessation in pregnancy: a systematic review and network meta-analysis
- 24 April 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 180, 108723
Clinical effects of pharmacological and electronic cigarette interventions for smoking cessation in pregnancy: a systematic review and network meta-analysis
- Open Access
- 16 April 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100789
Helping teens quit: A systematic review and network meta-analysis of smoking cessation interventions
- 16 April 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100789
Open AccessHelping teens quit: A systematic review and network meta-analysis of smoking cessation interventions
- 2 February 2026
- Published by Elsevier in Phytomedicine
- Vol. 153, 157915
Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
- 2 February 2026
- Published by Elsevier in Phytomedicine
- Vol. 153, 157915
Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
- Top Cited PapersOpen Access
- 23 January 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04027
Global prevalence of iron deficiency anaemia among children aged 5–12 years: a systematic review and meta-analysis
Iron is a micronutrient that plays a critical role in oxygen transportation, energy production, and overall physiological growth at every stage of life. About 70% of the body’s total iron is localised in red blood cells (haemoglobin) and muscle cells (myoglobin), where it facilitates the efficient delivery and utilisation of oxygen [1]. During childhood, iron […]
- 23 January 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04027
Top Cited PapersOpen AccessGlobal prevalence of iron deficiency anaemia among children aged 5–12 years: a systematic review and meta-analysis
Iron is a micronutrient that plays a critical role in oxygen transportation, energy production, and overall physiological growth at every stage of life. About 70% of the body’s total iron is localised in red blood cells (haemoglobin) and muscle cells (myoglobin), where it facilitates the efficient delivery and utilisation of oxygen [1]. During childhood, iron […]